These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of gamma aminobutyric acid (GABA) or GABA with glutamic acid decarboxylase (GAD) on the progression of type 1 diabetes mellitus in children: Trial design and methodology. Choat HM; Martin A; Mick GJ; Heath KE; Tse HM; McGwin G; McCormick KL Contemp Clin Trials; 2019 Jul; 82():93-100. PubMed ID: 31229619 [TBL] [Abstract][Full Text] [Related]
7. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes. Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292 [TBL] [Abstract][Full Text] [Related]
8. Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse. Beales PE; Hawa M; Williams AJ; Albertini MC; Giorgini A; Pozzilli P Acta Diabetol; 1995 Mar; 32(1):53-6. PubMed ID: 7612919 [TBL] [Abstract][Full Text] [Related]
9. Prevention of autoimmune diabetes in nonobese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Pleau JM; Fernandez-Saravia F; Esling A; Homo-Delarche F; Dardenne M Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):90-5. PubMed ID: 7606872 [TBL] [Abstract][Full Text] [Related]
10. Localization of gamma-aminobutyric acid and glutamic acid decarboxylase in the pancreas of the nonobese diabetic mouse. Saravia-Fernandez F; Faveeuw C; Blasquez-Bulant C; Tappaz M; Throsby M; Pelletier G; Vaudry H; Dardenne M; Homo-Delarche F Endocrinology; 1996 Aug; 137(8):3497-506. PubMed ID: 8754779 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes. Martin A; Mick GJ; Choat HM; Lunsford AA; Tse HM; McGwin GG; McCormick KL Nat Commun; 2022 Dec; 13(1):7928. PubMed ID: 36566274 [TBL] [Abstract][Full Text] [Related]
12. Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. Tian J; Lu Y; Zhang H; Chau CH; Dang HN; Kaufman DL J Immunol; 2004 Oct; 173(8):5298-304. PubMed ID: 15470076 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets. Suarez-Pinzon WL; Rabinovitch A Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121 [TBL] [Abstract][Full Text] [Related]
15. More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice. Seifarth C; Pop S; Liu B; Wong CP; Tisch R J Immunol; 2003 Jul; 171(1):469-76. PubMed ID: 12817032 [TBL] [Abstract][Full Text] [Related]
16. Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes. Mabley JG; Rabinovitch A; Suarez-Pinzon W; Haskó G; Pacher P; Power R; Southan G; Salzman A; Szabó C Mol Med; 2003; 9(3-4):96-104. PubMed ID: 12865945 [TBL] [Abstract][Full Text] [Related]
17. Inhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse. Ravanan R; Wong SF; Morgan NG; Mathieson PW; Smith RM Clin Exp Immunol; 2007 May; 148(2):368-72. PubMed ID: 17437424 [TBL] [Abstract][Full Text] [Related]